In the BioHarmony Drug Report Database

"Preview" Icon

Tropicamide

Mydriacyl (tropicamide) is a small molecule pharmaceutical. Tropicamide was first approved as Mydriacyl on 1982-01-01. It is used to treat iridocyclitis, iritis, and keratitis in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M5.

 

Trade Name

 

Mydriacyl
 

Common Name

 

tropicamide
 

ChEMBL ID

 

CHEMBL1200604
 

Indication

 

iridocyclitis, iritis, keratitis
 

Drug Class

 

Atropine derivatives

Image (chem structure or protein)

Tropicamide structure rendering